Neumora Therapeutics, Inc. (NMRA)
2.075
-0.12
(-5.25%)
USD |
NASDAQ |
Dec 09, 16:00
2.09
+0.02
(+0.72%)
After-Hours: 05:26
Neumora Therapeutics EPS Diluted (Quarterly): -0.3507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 0.6601 |
| CAMP4 Therapeutics Corp. | -0.5536 |
| Puma Biotechnology, Inc. | 0.1736 |
| Coherus Oncology, Inc. | -0.3021 |
| Ventyx Biosciences, Inc. | -0.3202 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.76M |
| Total Expenses (Quarterly) | 56.76M |
| Enterprise Value | 195.27M |
| Earnings Yield | -70.52% |
| Normalized Earnings Yield | -69.48 |